Cargando…

Primary gastric natural killer/T-cell lymphoma with diffuse CD30 expression and without CD56 expression: A case report

The majority of natural killer (NK)/T-cell lymphomas occur in the nasal cavity and rarely involve the stomach. They possess a specific immunophenotype, with the expression of cluster of differentiation (CD)56, CD2 and CD3ε, but without CD3 expression. Few cases of NK/T-cell lymphoma have partial CD3...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, LIZHI, ZHANG, PENGXIN, WEN, JINHUI, CHEN, XUEHUA, ZHANG, HUA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734030/ https://www.ncbi.nlm.nih.gov/pubmed/26893677 http://dx.doi.org/10.3892/ol.2015.4015

Ejemplares similares

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
por: Wang, Guan-Nan, et al.
Publicado: (2017)

CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
por: Li, Pengfei, et al.
Publicado: (2014)

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase
por: Yang, Jing, et al.
Publicado: (2022)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China
por: Feng, Yanfen, et al.
Publicado: (2017)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells
por: Qi, Jing, et al.
Publicado: (2022)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Increased early activation of CD56(dim)CD16(dim/-) natural killer cells in immunological non-responders correlates with CD4(+) T-cell recovery
por: Zhang, Qiu-Yue, et al.
Publicado: (2020)

CD56(−) extranodal natural killer (NK)/T-cell lymphoma, nasal type presenting as skin ulcers in a white man
por: Vainder, Charles, et al.
Publicado: (2016)

CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse
por: Taouk, Ghina, et al.
Publicado: (2019)

CD30(+) extranodal natural killer/T-cell lymphoma mimicking phlegmonous myositis: A case report
por: YANG, YAN-JIA, et al.
Publicado: (2014)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
por: Jagati, Ashish, et al.
Publicado: (2017)

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
Publicado: (1991)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

Endometrial CD56+ natural killer cells in women with recurrent implantation failure: An immunohistochemical study
por: Babayeva, Gulchin, et al.
Publicado: (2020)

Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity
por: Briones, Melissa R, et al.
Publicado: (2017)

Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
por: Peng, Yun-Peng, et al.
Publicado: (2016)

Aggressive Subcutaneous Panniculitis-Like CD30+ Peripheral T-Cell Lymphoma with Diffuse EBER Expression
por: Aneja, Amandeep, et al.
Publicado: (2014)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Beyond Uterine Natural Killer Cell Numbers in Unexplained Recurrent Pregnancy Loss: Combined Analysis of CD45, CD56, CD16, CD57, and CD138
por: Chiokadze, Maia, et al.
Publicado: (2020)

CD56 Expression in Odontogenic Cysts and Tumors
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2014)

Altered phenotypic and metabolic characteristics of FOXP3(+)CD3(+)CD56(+) natural killer T (NKT)-like cells in human malignant pleural effusion
por: Wang, Zi-Hao, et al.
Publicado: (2022)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3(+)CD8(+)CD56(+) Natural Killer T Population in Women with Recurrent Spontaneous Abortion
por: Rezayat, Fatemeh, et al.
Publicado: (2023)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis
por: Kullberg, Susanna, et al.
Publicado: (2021)

Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56(dim) Natural Killer Cells
por: Lajoie, Laurie, et al.
Publicado: (2017)

CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0bccp8ejs7b6fccr3qo6ovvae1